Ftse Mib
34.278,90
0,11%
DAX
18.493,92
0,30%
S&P 500
5.187,70
0,13%
NASDAQ
16.332,56
-0,10%
Bitcoin
62.268,23
-0,11%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Intersect ENT Inc (XENT) Intersect ENT Inc (XENT) Notizie

XENT

Intersect ENT (XENT)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:XENT
DataOraFonteTitoloSimboloCompagnia
10/02/202322:23Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:XENTIntersect ENT Inc
12/09/202219:11Edgar (US Regulatory)Withdrawal of a Registration Statement Withdrawal Request (rw Wd)NASDAQ:XENTIntersect ENT Inc
19/05/202222:50Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:XENTIntersect ENT Inc
18/05/202212:07Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:XENTIntersect ENT Inc
17/05/202200:58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XENTIntersect ENT Inc
13/05/202215:08Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:XENTIntersect ENT Inc
13/05/202215:01Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:XENTIntersect ENT Inc
13/05/202214:59Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:XENTIntersect ENT Inc
09/05/202223:28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:XENTIntersect ENT Inc
04/05/202222:43Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:XENTIntersect ENT Inc
29/04/202222:04Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:XENTIntersect ENT Inc
08/03/202222:14Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:XENTIntersect ENT Inc
08/03/202222:04Edgar (US Regulatory)Annual Report (10-k)NASDAQ:XENTIntersect ENT Inc
31/01/202220:35Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:XENTIntersect ENT Inc
25/01/202213:00Business WireReal-World Evidence Study Demonstrates Intersect ENT’s PROPEL® Sinus Implant Reduces Healthcare Resource UtilizationNASDAQ:XENTIntersect ENT Inc
02/11/202121:15Business WireIntersect ENT Reports Third Quarter 2021 Financial ResultsNASDAQ:XENTIntersect ENT Inc
28/10/202113:00Business WireFirst Implants of PROPEL® Contour in Patients with Chronic Rhinosinusitis Following Frontal Sinus Surgery in EuropeNASDAQ:XENTIntersect ENT Inc
30/09/202122:02Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:XENTIntersect ENT Inc
19/08/202114:47Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:XENTIntersect ENT Inc
09/08/202120:47PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Intersect ENT, Inc.NASDAQ:XENTIntersect ENT Inc
09/08/202117:07TipRanksMedtronic Gains Investor Confidence with Intersect BuyoutNASDAQ:XENTIntersect ENT Inc
09/08/202111:55TipRanksIntersect ENT’s Q2 Results Miss Expectations; Shares Jump on Acquisition NewsNASDAQ:XENTIntersect ENT Inc
06/08/202116:24Dow Jones NewsIntersect ENT Shares Rise on Medtronic Takeover DealNASDAQ:XENTIntersect ENT Inc
06/08/202113:48Dow Jones NewsMedtronic to Buy Intersect ENT for $28.25/ShareNASDAQ:XENTIntersect ENT Inc
06/08/202113:15Business WireIntersect ENT Reports Second Quarter 2021 Financial ResultsNASDAQ:XENTIntersect ENT Inc
06/08/202113:00PR Newswire (US)Medtronic to Acquire Intersect ENTNASDAQ:XENTIntersect ENT Inc
26/07/202113:00Business WireU.S Nationwide Commercial Availability of the VenSure™ Balloon Sinus Dilation System and Cube™ Navigation System Highlight Intersect ENT’s Continued Commitment to Providing Innovative, Solutions for Patients with Chronic RhinosinusitisNASDAQ:XENTIntersect ENT Inc
23/07/202114:00Business WireIntersect ENT to Report Second Quarter 2021 Financial Results on August 6NASDAQ:XENTIntersect ENT Inc
22/07/202122:05Business WireIntersect ENT Announces Preliminary Revenue for Second Quarter of 2021 and Closing of $60 Million Term LoanNASDAQ:XENTIntersect ENT Inc
20/05/202113:46Business WireIntersect ENT Receives CE Mark Approval for PROPEL® Contour for Patients with Chronic Rhinosinusitis Following Frontal Sinus...NASDAQ:XENTIntersect ENT Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:XENT

La tua Cronologia

BIT
UCG
Unicredit
BIT
RACE
Ferrari NV
BIT
BAMI
Banco BPM
BIT
LDO
Leonardo
BIT
STLAM
Stellantis NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ISP
Intesa Sanpaolo
BIT
CPR
Davide Campari
BIT
ENEL
Enel
BIT
BPE
Bper Banca
BIT
MAIRE
Maire Tecnimont
BIT
ENI
Eni
BIT
STMMI
ST Microelectronics
BIT
BPSO
Banca Popolare di Sondrio
BIT
G
Generali
BIT
SRG
Snam
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network